PMID: 16508393Mar 2, 2006Paper

Propofol pharmacokinetics and pharmacodynamics for depth of sedation in nonventilated infants after major craniofacial surgery

Anesthesiology
M Y PeetersM Danhof

Abstract

To support safe and effective use of propofol in nonventilated children after major surgery, a model for propofol pharmacokinetics and pharmacodynamics is described. After craniofacial surgery, 22 of the 44 evaluated infants (aged 3-17 months) in the pediatric intensive care unit received propofol (2-4 mg . kg-1 . h-1) during a median of 12.5 h, based on the COMFORT-Behavior score. COMFORT-Behavior scores and Bispectral Index values were recorded simultaneously. Population pharmacokinetic and pharmacodynamic modeling was performed using NONMEM V (GloboMax LLC, Hanover, MD). In the two-compartment model, body weight (median, 8.9 kg) was a significant covariate. Typical values were Cl = 0.70 . (BW/8.9)0.61 l/min, Vc = 18.8 l, Q = 0.35 l/min, and Vss = 146 l. In infants who received no sedative, depth of sedation was a function of baseline, postanesthesia effect (Emax model), and circadian night rhythm. In agitated infants, depth of sedation was best described by baseline, postanesthesia effect, and propofol effect (Emax model). The propofol concentration at half maximum effect was 1.76 mg/l (coefficient of variation = 47%) for the COMFORT-Behavior scale and 3.71 mg/l (coefficient of variation = 145%) for the Bispectral Index. Pro...Continue Reading

References

Feb 1, 1992·Journal of Pediatric Psychology·B AmbuelJ L Blumer
Jun 1, 1997·Journal of Clinical Pharmacology·E I Ette
Apr 29, 1998·Journal of Chromatography. B, Biomedical Sciences and Applications·C A KnibbeR Lange
Mar 11, 1999·Anesthesia and Analgesia·J W SleighM Steyn-Ross
Mar 17, 2000·Anesthesiology·J Schüttler, H Ihmsen
Jul 14, 2001·Clinical Pharmacology and Therapeutics·C D van der MarelD Tibboel
Oct 30, 2001·Anesthesia and Analgesia·D W KimP F White
Oct 24, 2002·British Journal of Clinical Pharmacology·Catherijne A J KnibbeMeindert Danhof
Jun 10, 2003·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Noreen CrainMurray M Pollack
Aug 19, 2004·Acta Anaesthesiologica Scandinavica·R CalvoJ C Lukas
Sep 24, 2004·The Cancer Journal·Dominique Delbeke, William H Martin
Oct 27, 2004·Anesthesiology·Anthony G DoufasDaniel I Sessler
Jan 8, 2005·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Erwin IstaMatthijs de Hoog
Mar 15, 2005·British Journal of Anaesthesia·S A PrinsD Tibboel
Jun 14, 2005·British Journal of Clinical Pharmacology·Catherijne A J KnibbeMeindert Danhof

❮ Previous
Next ❯

Citations

Nov 3, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Hossam El-Beheiry, Brian Kavanagh
Nov 13, 2007·European Journal of Clinical Pharmacology·Mariska Y M PeetersCatherijne A J Knibbe
Jan 31, 2012·Pharmaceutical Research·Chenguang WangCatherijne A J Knibbe
Apr 12, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Shogo J MiyagiAbby C Collier
Oct 5, 2007·Annual Review of Pharmacology and Toxicology·B J Anderson, N H G Holford
Dec 15, 2010·Pharmaceutical Research·Elke H J KrekelsCatherijne A J Knibbe
Mar 27, 2010·European Journal of Clinical Pharmacology·Roosmarijn F W De CockCatherijne A J Knibbe
May 5, 2007·Current Opinion in Anaesthesiology·Andrew J Davidson
Jun 30, 2006·European Journal of Pediatrics·Brian J AndersonNicholas H G Holford
Jul 15, 2015·Expert Opinion on Drug Metabolism & Toxicology·Brian J Anderson, Jacqueline A Hannam
Dec 2, 2010·Expert Opinion on Drug Metabolism & Toxicology·Catherijne A J KnibbeMeindert Danhof
Feb 4, 2010·Journal of Pharmaceutical Sciences·Iftekhar Mahmood
Dec 12, 2012·Annales Françaises D'anesthèsie Et De Rèanimation·I ConstantN Louvet
Nov 3, 2010·Best Practice & Research. Clinical Anaesthesiology·Brian J Anderson, Karel Allegaert
Jan 9, 2008·Paediatric Anaesthesia·Thomas EngelhardtBruno Bissonnette
Jan 10, 2012·Paediatric Anaesthesia·Brian J Anderson
Nov 19, 2010·Paediatric Anaesthesia·Ann E Rigby-Jones, J Robert Sneyd
May 18, 2010·Paediatric Anaesthesia·Isabelle Constant, Agnes Rigouzzo
Aug 23, 2016·The Journal of Pharmacy and Pharmacology·Manuel A BaarslagDick Tibboel
Dec 31, 2019·Paediatric Anaesthesia·Gillian R LauderThomas Engelhardt
May 21, 2020·Journal of Clinical Pharmacology·Abraham J ValkenburgElke H J Krekels
Aug 1, 2012·Clinical Pharmacokinetics·Jeroen DiepstratenAlexander A Vinks
Nov 1, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Hossam El Beheiry, Brian Kavanagh
Oct 10, 2018·Journal of Pharmacokinetics and Pharmacodynamics·Robin MicheletAn Vermeulen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.